ONO-8130   Click here for help

GtoPdb Ligand ID: 11536

Compound class: Synthetic organic
Comment: ONO-8130 is an EP1 receptor antagonist [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 9
Topological polar surface area 133.42
Molecular weight 500.14
XLogP 5.24
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(CN(S(=O)(=O)c1scc(n1)C)c1cc2CCCc2cc1OCc1ccc(cc1)C(=O)O)C
Isomeric SMILES CC(CN(S(=O)(=O)c1scc(n1)C)c1cc2CCCc2cc1OCc1ccc(cc1)C(=O)O)C
InChI InChI=1S/C25H28N2O5S2/c1-16(2)13-27(34(30,31)25-26-17(3)15-33-25)22-11-20-5-4-6-21(20)12-23(22)32-14-18-7-9-19(10-8-18)24(28)29/h7-12,15-16H,4-6,13-14H2,1-3H3,(H,28,29)
InChI Key IOXMDBQCUCDLAF-UHFFFAOYSA-N
References
1. Maruyama T, Okada H, Konemura T. (2015)
Therapeutic agent for urinary excretion disorder.
Patent number: US9181187B2. Assignee: Ono Pharmaceutical Co Ltd. Priority date: 16/02/2007. Publication date: 10/11/2015.
2. Säfholm J, Dahlén SE, Delin I, Maxey K, Stark K, Cardell LO, Adner M. (2013)
PGE2 maintains the tone of the guinea pig trachea through a balance between activation of contractile EP1 receptors and relaxant EP2 receptors.
Br J Pharmacol, 168 (4): 794-806. [PMID:22934927]